MTE #16: Hidden in the Chart—Leveraging the Electronic Health Records to Detect Fibrotic Metabolic Dysfunction–Associated Steatohepatitis (Ticketed)

Early identification of persons at risk for fibrotic metabolic dysfunction–associated steatohepatitis (MASH) remains a major gap in care despite the availability of validated noninvasive tools. Presenters examine how electronic health record (EHR)–enabled strategies can be used to systematically identify, risk stratify, and triage patients with suspected MASH in real-world clinical settings. Topics include EHR–based case finding algorithms, automated fibrosis risk scores, clinical decision support, and referral pathways, as well as practical challenges related to workflow integration, equity, and implementation across diverse practice environments.